Clinical Trials Browser

Phase 2 × eribulin × Head & Neck × Clear all

NCT01613768 2018-09-28

Eribulin Mesylate in Treating Patients With Recurrent or Metastatic Salivary Gland Cancer

Phase 2 Completed

29 enrolled 12 charts

Salivary Gland Neoplasms

NCT00337129 2015-08-25

S0618 E7389 in Treating Patients With Metastatic or Recurrent Head and Neck Cancer

Phase 2 Completed

42 enrolled 8 charts

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms